These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18818197)

  • 21. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.
    McLean KJ; Munro AW
    Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis.
    McLean KJ; Cheesman MR; Rivers SL; Richmond A; Leys D; Chapman SK; Reid GA; Price NC; Kelly SM; Clarkson J; Smith WE; Munro AW
    J Inorg Biochem; 2002 Sep; 91(4):527-41. PubMed ID: 12237220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Function Analysis of the Essential
    Padayachee T; Lamb DC; Nelson DR; Syed K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3.
    Ost TW; Miles CS; Munro AW; Murdoch J; Reid GA; Chapman SK
    Biochemistry; 2001 Nov; 40(45):13421-9. PubMed ID: 11695888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of
    Bajrai LH; Khateb AM; Alawi MM; Felemban HR; Sindi AA; Dwivedi VD; Azhar EI
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QM/MM study of the C-C coupling reaction mechanism of CYP121, an essential cytochrome p450 of Mycobacterium tuberculosis.
    Dumas VG; Defelipe LA; Petruk AA; Turjanski AG; Marti MA
    Proteins; 2014 Jun; 82(6):1004-21. PubMed ID: 24356896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450.
    Leys D; Mowat CG; McLean KJ; Richmond A; Chapman SK; Walkinshaw MD; Munro AW
    J Biol Chem; 2003 Feb; 278(7):5141-7. PubMed ID: 12435731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoelectrospray ionization mass spectrometric study of Mycobacterium tuberculosis CYP121-ligand interactions.
    Duffell KM; Hudson SA; McLean KJ; Munro AW; Abell C; Matak-Vinković D
    Anal Chem; 2013 Jun; 85(12):5707-14. PubMed ID: 23675886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Gray JL; Gilbert SH; Coyne AG; McLean KJ; Davis HJ; Munro AW; Abell C
    ChemMedChem; 2016 Sep; 11(17):1924-35. PubMed ID: 27432475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
    Child SA; Ghith A; Bruning JB; Bell SG
    J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel Antimycobacterials.
    Brengel C; Thomann A; Schifrin A; Allegretta G; Kamal AAM; Haupenthal J; Schnorr I; Cho SH; Franzblau SG; Empting M; Eberhard J; Hartmann RW
    ChemMedChem; 2017 Oct; 12(19):1616-1626. PubMed ID: 28815923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?
    Ortega Ugalde S; Boot M; Commandeur JNM; Jennings P; Bitter W; Vos JC
    Appl Microbiol Biotechnol; 2019 May; 103(9):3597-3614. PubMed ID: 30810776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis.
    Mowat CG; Leys D; McLean KJ; Rivers SL; Richmond A; Munro AW; Ortiz Lombardia M; Alzari PM; Reid GA; Chapman SK; Walkinshaw MD
    Acta Crystallogr D Biol Crystallogr; 2002 Apr; 58(Pt 4):704-5. PubMed ID: 11914502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
    Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target].
    Lu Y; Qiao F; You XF; Yang XY
    Yao Xue Xue Bao; 2014 Apr; 49(4):427-34. PubMed ID: 24974457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-cyanopyridine, a versatile spectroscopic probe for cytochrome P450 BM3.
    Ost TW; Clark JP; Anderson JL; Yellowlees LJ; Daff S; Chapman SK
    J Biol Chem; 2004 Nov; 279(47):48876-82. PubMed ID: 15364917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.
    Chen Z; Ost TW; Schelvis JP
    Biochemistry; 2004 Feb; 43(7):1798-808. PubMed ID: 14967021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Activity Relationships of
    Rajput S; McLean KJ; Poddar H; Selvam IR; Nagalingam G; Triccas JA; Levy CW; Munro AW; Hutton CA
    J Med Chem; 2019 Nov; 62(21):9792-9805. PubMed ID: 31618032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Coyne AG; McLean KJ; James GG; Levy CW; Marino LB; de Carvalho LP; Chan DS; Hudson SA; Surade S; Leys D; Munro AW; Abell C
    J Med Chem; 2016 Apr; 59(7):3272-302. PubMed ID: 27002486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.